These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 35032607)
1. De-novo designed β-lysine derivatives can both augment and diminish the proliferation rates of E. coli through the action of Elongation Factor P. McDonnell CM; Ghanim M; Mike Southern J; Kelly VP; Connon SJ Bioorg Med Chem Lett; 2022 Mar; 59():128545. PubMed ID: 35032607 [TBL] [Abstract][Full Text] [Related]
2. Post-translational modification by β-lysylation is required for activity of Escherichia coli elongation factor P (EF-P). Park JH; Johansson HE; Aoki H; Huang BX; Kim HY; Ganoza MC; Park MH J Biol Chem; 2012 Jan; 287(4):2579-90. PubMed ID: 22128152 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory. Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628 [TBL] [Abstract][Full Text] [Related]
4. Genetic encoding of the post-translational modification 2-hydroxyisobutyryl-lysine. Knight WA; Cropp TA Org Biomol Chem; 2015 Jun; 13(23):6479-81. PubMed ID: 25999185 [TBL] [Abstract][Full Text] [Related]
5. Design of New Antibacterial Enhancers Based on AcrB's Structure and the Evaluation of Their Antibacterial Enhancement Activity. Song Y; Qin R; Pan X; Ouyang Q; Liu T; Zhai Z; Chen Y; Li B; Zhou H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869748 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of azithromycin glycosyl derivatives as potential antibacterial agents. Zhang L; Chai X; Wang B; Yu S; Hu H; Zou Y; Zhao Q; Meng Q; Wu Q Bioorg Med Chem Lett; 2013 Sep; 23(18):5057-60. PubMed ID: 23937982 [TBL] [Abstract][Full Text] [Related]
7. Predicting the pathway involved in post-translational modification of elongation factor P in a subset of bacterial species. Bailly M; de Crécy-Lagard V Biol Direct; 2010 Jan; 5():3. PubMed ID: 20070887 [TBL] [Abstract][Full Text] [Related]
8. Extended targeting potential and improved synthesis of Microcin C analogs as antibacterials. Vondenhoff GH; Dubiley S; Severinov K; Lescrinier E; Rozenski J; Van Aerschot A Bioorg Med Chem; 2011 Sep; 19(18):5462-7. PubMed ID: 21855353 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring. Luo J; Yang QE; Yang YY; Tang YZ; Liu YH Chem Biol Drug Des; 2016 Nov; 88(5):699-709. PubMed ID: 27273921 [TBL] [Abstract][Full Text] [Related]
10. Recent developments of quinolone-based derivatives and their activities against Escherichia coli. Gao F; Wang P; Yang H; Miao Q; Ma L; Lu G Eur J Med Chem; 2018 Sep; 157():1223-1248. PubMed ID: 30193220 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance. Gu X; Pisoni LA; Wang Y; Song D; Sykes MJ; Qin Y; Semple SJ; Polyak SW; Venter H; Ma S Bioorg Chem; 2020 Dec; 105():104394. PubMed ID: 33120321 [TBL] [Abstract][Full Text] [Related]
12. Optimization of activity localization of quinoline derivatives: Design, synthesis, and dual evaluation of biological activity for potential antitumor and antibacterial agents. Jin G; Li Z; Xiao F; Qi X; Sun X Bioorg Chem; 2020 Jun; 99():103837. PubMed ID: 32299019 [TBL] [Abstract][Full Text] [Related]
13. Potentiating 1-(2-hydroxypropyl)-2-styryl-5-nitroimidazole derivatives against antibacterial agents: design, synthesis and biology analysis. Wang ZC; Duan YT; Qin YJ; Wang PF; Luo Y; Wen Q; Yang YA; Sun J; Hu Y; Sang YL; Zhu HL Eur J Med Chem; 2013 Jul; 65():456-63. PubMed ID: 23770447 [TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae. Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888 [TBL] [Abstract][Full Text] [Related]
16. Lys34 of translation elongation factor EF-P is hydroxylated by YfcM. Peil L; Starosta AL; Virumäe K; Atkinson GC; Tenson T; Remme J; Wilson DN Nat Chem Biol; 2012 Aug; 8(8):695-7. PubMed ID: 22706199 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents. Kadhim ZY; Alqaraghuli HGJ; Abd MT Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379 [TBL] [Abstract][Full Text] [Related]
18. Urea/thiourea derivatives of quinazolinone-lysine conjugates: synthesis and structure-activity relationships of a new series of antimicrobials. Suresha GP; Suhas R; Kapfo W; Gowda DC Eur J Med Chem; 2011 Jun; 46(6):2530-40. PubMed ID: 21481990 [TBL] [Abstract][Full Text] [Related]